AroCell Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AroCell
Access all reports
AroCell AB is a Swedish diagnostics company that develops and markets blood and urine sample tests primarily for monitoring cancer, particularly breast, prostate, and bladder cancers. Its main product is the AroCell TK 210 ELISA, an immunoassay kit that measures Thymidine Kinase 1 protein levels in blood samples, helping to assess cell proliferation in cancer patients. Another key product, UBC Rapid, is used for diagnosing and monitoring bladder cancer. AroCell is headquartered in Stockholm, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
AROC
Country
🇸🇪 Sweden